Related Experiment Video
Updated: Apr 22, 2026

07:16
Assembly and Operation of an Acoustofluidic Device for Enhanced Delivery of Molecular Compounds to Cells
Published on: January 21, 2021
2.7K
Sequential intracellular delivery of genetic coding molecules using an acoustic electric microfluidic platform
Michelle Zhang1, Aida Z Taravatfard2, Mohammad Aghaamoo3
1School of Pharmacy and Pharmaceutical Sciences, University of California, Irvine, CA 92697, USA.
Lab on a Chip
|April 21, 2026
Summary
This study introduces acoustic microstreaming for sequential cell transfection, improving delivery efficiency for genetic therapies. The AESOP platform enhances gene editing and cell engineering by overcoming co-transfection limitations.
Area of Science:
- Cell Biology
- Biotechnology
- Bioengineering
Background:
- Intracellular delivery of genetic molecules is crucial for cell biology and gene therapies.
- Current co-transfection methods face limitations in efficiency and precision due to cargo interactions.
- Next-generation cell engineering requires precise delivery of multiple genetic payloads.
Purpose of the Study:
- To develop a novel method for efficient sequential intracellular transfection of genetic molecules.
- To overcome the limitations of traditional co-transfection techniques.
- To advance cell and gene therapies reliant on multiplexed intracellular delivery.
Main Methods:
- Utilized acoustic microstreaming in a microfluidic platform (AESOP).
- Generated acoustic microstreaming vortices to trap cells and enable sequential molecule delivery without external pumps.
- Employed a combination of mechanical shearing and electric fields for transfection.
Main Results:
- Demonstrated up to a 7-fold increase in transfection efficiency compared to co-transfection.
- Sequential delivery via AESOP eliminated cargo competition, enhancing precision.
- Successfully transfected plasmid DNA and Cas9 ribonucleoprotein (RNP) sequentially.
Conclusions:
- AESOP provides an efficient and precise method for sequential intracellular transfection.
- This technology supports advancements in cancer immunotherapy, mRNA therapies, and CRISPR-Cas9 gene editing.
- The platform addresses key challenges in multiplexed intracellular delivery for therapeutic applications.

